chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been reported in a study. The report includes VAERS reports following PNEUMOVAX 23 or Pneumococcal polysaccharide vaccine (PPSV23) brand unknown after 2002. The report includes reports information from 01-JAN-1990 to 31-JAN-2014. This spontaneous report as received from a other health professional refers to 4 patients. The median age of the patients was 69 years old; range being 23 to 98 years. Between 01-JAN-1990 and 31-DEC-2013 patients were vaccinated with PNEUMOVAX 23. On an unknown date the patients experienced death. The outcome of death was reported as fatal. The cause of death was reported as 'other non infectious'. The death of the patients was confirmed with medical records, autopsy reports and/or death certificates. The report has been split into cases according to cause of death. This case is linked to same reporter linked cases 1406USA003857 (respiratory disorder), 1406USA003863 (Unknown), 1406USA003858 (other infectious disorder), 1406USA003860 (gastrointestinal), 1406USA003861 (Neurological), 1406USA003862 (Undetermined) and 1406USA003351 (Cardiovascular). Additional information has been requested.
Platelets dropped to 12,000/Platelet was dropped to 25 (units not specified); This is a spontaneous report from a contactable healthcare professional (female). A 71-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EN6201), second dose via an unspecified route of administration, administered in Arm Right on 16Feb2021 15:45, single dose for covid-19 immunisation. Medical history included ITP, from an unknown date. The patient had her first dose of bnt162b2 vaccine on an unspecified date for COVID-19 immunisation. Concomitant medication included methylphenidate hydrochloride (CONCERTA). Platelet was dropped to 25 (units not specified). Patient's platelets was dropped all the way after the second dose (16Feb2021) and she had to take Prednisone. Start date of event, Nurse stated, 4 days later. (Confirmed the date as 19Feb2021). CBC Date: Nurse stated, Last one I had it was every day since the day before the vaccine and today. Results: Nurse stated, platelets went down to 12,000. Patient is now on Prednisone, so her platelets are up. The outcome of the event was unknown.; Sender's Comments: Based on a plausible temporal association, a possible contributory role of vaccination with BNT162B2 to the reported event platelets decreased cannot be excluded. The history of ITP may have provided the contribution to the event.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
COVID Symptoms began sometime in October unsure of specific dates. I had a bad headache, neck ache, dry cough, wheezing when breathing. My company provides onsite testing and I did a nasal swab  COVID test and it came back positive. Symptoms lasted probably 5 days. I do still have a little bit of chest congestion but it might be that time of the year and the change of humidity.
Shoulder pain that has persisted past 48 hours. Severe, aching pain has developed, and I can barely move my shoulder now; Bruising and swelling remain at the sight of the injection; Bruising and swelling remain at the sight of the injection; This is a spontaneous report from a contactable consumer or other non hcp. A 54-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot number was not reported) dose number unknown via an unspecified route of administration in Arm Left on 26Feb2021 15:30 (age at vaccination 54years old) as single dose for covid-19 immunisation. Medical history included cardiac disorder, drug hypersensitivity all from an unknown date and unknown if ongoing. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication(s) included metoprolol (METOPROLOL); prasugrel (PRASUGREL) all taken for an unspecified indication, start and stop date were not reported. Since the vaccination, the patient had not been tested positive for COVID-19. On 26Feb2021 at 15:30 the patient experienced shoulder pain that has persisted past 48 hours. severe, aching pain has developed, and I can barely move my shoulder now, bruising and swelling remain at the sight of the injection. The patient received treatment with Ibuprofen for the adverse events. The clinical outcome of the event was not recovered. Therapeutic measures were taken as a result of shoulder pain that has persisted past 48 hours. severe, aching pain has developed, and I can barely move my shoulder now, bruising and swelling remain at the sight of the injection.  No follow up attempts are possible. Information about Lot/batch number cannot be obtained.
It was reported that a male in his late twenties received Fluzone WV '99-'00 on 10/26/99. Within 12 hours, post vax, the pt experienced "weakness, headache, fever and general malaise". This is one of three similar cases by the same reporter: U199900891 through U199900893. No further information is available at this time. Additional information provided 11/22/99, stated the following; "subsequently it was learned that this employee, who called in sick with the symptoms noted above, was not ill."
In site swelling, pain erythema and fever. KEFLEX 500 Mg 2 twice daily and prednisone 50 twice daily for 6 days.
Immediately after receiving the vaccine, acquired hives on his face. The hives spread to both arms and the right side of his chest. Monitored in clinic for about 45 minutes.  Dr told mom it is ok to give OTC Benadryl.
7 days after receiving vaccine, severe itching, redness, swelling and pain appeared at injection site. These symptoms were not present the first 6 days after the injection.
Pt reports day after injection was feverish, achey, experienced n/v, headache.  Then her face broke out in swollen, red, painful areas.  Nurse Practioner felt could be shingles, had her come back this am for follow up with Doctor.
dizziness, heart palpitation, and anxiety after 1-2 minutes; dizziness, heart palpitation, and anxiety after 1-2 minutes; dizziness, heart palpitation, and anxiety after 1-2 minutes; my heart racing/palpitating like having an anxiety attack; my heart racing/palpitating like having an anxiety attack; This is a spontaneous report from a contactable consumer (patient). A 69-year-old non-pregnant female patient received BNT162B2 (COMIRNATY, solution for injection, Lot Number: Unknown), via intramuscular route of administration in left arm on 31Jan2021 11:45 1st dose, single for covid-19 immunisation. The patient medical history included fibromyalgia, arthritis, postnasal drip and allergy to penicillin, sulfa drugs, dust mites, some trees. Concomitant medication included Bupropion, Trazodone and Lamotrigine; all were taken for an unspecified indication, start and stop date were not reported. Patient did not receive any other vaccine in four weeks. Patient did not have COVID prior vaccination. Patient was not COVID tested post vaccination. On 31Jan2021 at 11:45 AM the patient experienced dizziness, heart palpitation, and anxiety after 1-2 minutes. About a minute or two after the shot, I experienced dizziness, my heart racing/palpitating like having an anxiety attack, which I rarely have. It lasted around 15 to 30 minutes. A doctor was on hand. An assistant checked my heart rate and blood pressure and was told it was fine. Patient did not receive any treatment for events. Patient had blood pressure/pulse taken. Outcome of the events was recovered on 31Jan2021.  Information on the lot/batch number has been requested. Follow-up attempts are completed. No further information is expected.
Sparse vesiculopapular rash all over body including scalp. One exanthem in Rt buccal mucosa.
Body aches, stiffness in muscles, chill but no fever, soreness at injection site and up through neck on left side, extreme tiredness and exhaustion. Side effects were most severe the evening of and day after the vaccine was administered. Took a sick day from work to rest and treated with ibuprofen and fluids.  2 days after the vaccine side effects are less but still present and injection site is red, warm, and swollen.
Lot # 029L20A 1/28/21 (First dose)   Patient received first dose of Moderna COVID vaccine on 1/28/21 (Lot # 029L20A).   She noticed a small red spot and itch one day after she received her vaccine and continued to get bigger.  Four day later, it got worse, she developed lump, swollen, redness but no puss.  It was firm at injection site, tender to the touch and warmer feels compared to the skin around. Patient was instructed to use Triamcinolone and topical Benadryl to help with symptoms.
An area approximately 7 cm in diameter just below inj site became inflamed, warm to touch & sl. hardened. Referred to PCP who treated with oral ATB.
I was at a medical appointment one day when I got dizzy, and my lips and tongue became numb. I also started talking gibberish. This lasted about 45 seconds or so and then went away. This was the first transient ischemic attack I had. My wife looked up my symptoms on the Internet and told me she thought I had had a TIA. A few days later, I went to the ER. I underwent various tests. I spent one day and one night in the hospital and went home the next day. I was given generic apixaban, which caused an allergic reaction. My doctor then ordered the name brand Eliquis, which caused no problems. I still take it twice a day, and my doctor says I'll be taking it twice a day for the rest of my life. When I came home from the hospital, I did well for a few months afterwards. I then got a smart watch, which announced to me one day that I was in atrial fibrillation and that I should go to the hospital immediately, which I did. At the hospital, it was confirmed that I was in atrial fibrillation. They gave me medication to reduce my heartrate, and it worked. I was then subsequently released as an outpatient. After that, I did fine until October 2022. One day, I had another transient ischemic attack. I was admitted to the hospital. Again, I underwent various tests, such as CT scans and other imaging. These confirmed that I had experienced a TIA. I stayed overnight. I saw my cardiologist sometime afterwards, and he decided I needed blood thinner and something to bring my blood pressure down. I was given ezetimibe (10 mg), metoprolol tartrate (25 mg), and lisinopril (20 mg). I have also been taking low-dose baby aspirin ever since then. Ever since October 2022, I haven't had any more problems.
Information has been received from a physician assistant referring to a patient of unknown age and gender. On 31-JUL-2012 the patient was vaccinated with the first dose of quadrivalent human papillomavirus recomb. vaccine (unidentified Merck) (strength, dose, frequency and route were unknown). On 09-MAR-2016 the patient was vaccinated with the second dose of quadrivalent human papillomavirus recomb. vaccine (unidentified Merck) (strength, dose, frequency and roué were unknown). No adverse events were reported. Additional information has been requested.
no adverse event; 56 adults patients received doses after its expiration date Jul 13, 2022; This spontaneous case was reported by a pharmacist and describes the occurrence of NO ADVERSE EVENT (no adverse event) and EXPIRED PRODUCT ADMINISTERED (56 adults patients received doses after its expiration date Jul 13, 2022) in an adult patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 004m21a) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced NO ADVERSE EVENT (no adverse event) and EXPIRED PRODUCT ADMINISTERED (56 adults patients received doses after its expiration date Jul 13, 2022). At the time of the report, NO ADVERSE EVENT (no adverse event) and EXPIRED PRODUCT ADMINISTERED (56 adults patients received doses after its expiration date Jul 13, 2022) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.   For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (56 adults patients received doses after its expiration date Jul 13, 2022).    No concomitant and treatment medications were reported.  It was unknown whether patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. It was stated that there were no remaining vials unused of that lot number and reminded the caller that no patients should receive doses from expired vials. Dose was administered after 30-day Use by Date or after manufacturer date of expiry. Vial did not undergo any temperature excursions. It was unknown if the vial was initially stored in the refrigerator.   This case was linked to US-MODERNATX, INC.-MOD-2023-701125 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-701125:Master case
had hives on back and L arm 1 inch medial to vaccine injection site; no lip or tongue edema, no wheezing or stridor Treatment dugs:
Information has been received from an office manager concerning a female (age not reported) who on 03-APR-2007 was vaccinated with the third dose of Gardasil. Concomitant medication was not reported. Subsequently on an unspecified date after the patient received her third dose of Gardasil, the patient developed a lump and soreness at the injection site. The patient sought unspecified medical attention. The patient's lump and soreness at injection site persisted. Additional information has been requested.
Post vax, this pt experienced rash-like bumps on the back and torso which lasted approximately 3 days. Subsequently, the pt recovered from rash-like bumps. No further information is available.
Body aches, fatigue, and low grade fever (99.2 to 101.2) for 24 hours.   Symptoms started about 12 hours after vaccination.
Information has been received from a pharmacist concerning a male patient who on an unspecified date was vaccinated with a dose of PNEUMOVAX 23 (lot# not reported). Subsequently the patient experienced severe swelling. At the time of this report, the patient's outcome was not reported. This is one of several reports from the same source. Additional information has been requested.
pt states that she had fatigue later on in the day after getting her vax.  She woke up early next day w/ joint pain, chills, body aches, 101 fever, vomiting and diarrhea.  On 2/6/2021  pt did not have fever but had body aches, joint pain and headache.  On 2/7 /2021  pt stated she felt a little better but by 2/9 /2021 she started having 101. 2 fever along with body aches, joint pain, fatigue, weakness and a rash developed on her lower abdomen which is spreading to her upper torso and is inflamed and itching.  She was tested for Covid virus and is waiting on the test results.  She will contact her PCP after receiving her test results for medical advice.
My daughter got this shot and was seriously ill for 2wks; This case was reported by a consumer via  interactive digital media and described the occurrence of unwell in a female patient who received Men B NVS (Meningococcal B vaccine) for prophylaxis.   On an unknown date, the patient received Meningococcal B vaccine. On an unknown date, unknown after receiving Meningococcal B vaccine, the patient experienced unwell (serious criteria other: Serious as per reporter). On an unknown date, the outcome of the unwell was recovered/resolved.   It was unknown if the reporter considered the unwell to be related to Meningococcal B vaccine.  Additional details were reported as follows: The reporter was patient's parent. The age at vaccination was not reported. The patient received Meningococcal B vaccine and was seriously ill for 2 weeks. The reporter did not recommend getting this vaccine. The follow-up would not possible as no contact details were available.
Patient came to clinic to receive a Pfizer COVID vaccine at a mass vaccine clinic. Clinic was unaware patient received a dose of Janssen two days prior. Pharmacy was notified over one year later. No known adverse effects were reported.
Information has been received from a consumer, a Medical Assistant and a practice administrator concerning baby who was born from an 18 year old female patient with asthma, dyslexia and drug intolerance to BENADRYL and to AUGMENTIN, and who on 20-MAY-2011 was vaccinated with her first dose of GARDASIL (lot number 666597/0768Z) (dose, route and site not provided). On the same day the patient also received a dose of VARIVAX (lot number, dose, route and site not provided), a dose of MENACTRA and a dose of Tdap. On 22-JUL-2011, the patient received the second dose of GARDASIL (lot # 0819Z) (dose, route and site not provided). The patient did not receive any other vaccinations that day. On 23-Dec-2011, the patient received the third dose of GARDASIL (lot # 670048/0963AA) (dose, route and site not provided). The patient did not receive any other vaccinations that day. The patient's mother was pregnant at the time she received her third and last dose of GARDASIL. It was reported that the baby was born and had hydrocephalia. The patient's mother did not provide any information about her baby. It was reported that the baby may had been hospitalized at that time. At the time of the report the patient's outcome was unknown. The mother's events were captured in WAES # 1206USA02525. Additional information has been requested.
No reported adverse reactions. Patient was given high-dose vaccine as ordered by physician. Physician examined patient and felt due to his recent illness, would benefit from high-dose vaccine, even though he is not of age range.  Physician has since reviewed the vaccination guidelines to recognize there is no indication at this time for giving high-dose to patients younger than specified range. Patient was notified and has had no effects from the adverse effects from the vaccine.
PATIENT RECEIVED AN EXPIRED DOSE OF THE JANSSEN COVID-19 VACCINE ON 10/27/21. PHARMACY NOTIFIED OF MISTAKE ON 3/06/2022. ATTEMPTED TO CONTACT PATIENT TO REVACCINATE BUT PATIENT HAS NOT RETURNED OUR CALL.
Patient had received 2nd dose improperly and there was improper filing/recordkeeping resulting in receiving the 3rd dose.
Initial misuse report received from a healthcare professional on 11 October 2013. This case is a part of 1 cluster cases and is linked to case number 2013SA103882 (same reporter, events after FLUZONE ID, lot number: UT4725AA). The two patients of age between 18-49 years received FLUZONE ID (batch number: UT4725AA, expiry date: 19 April 2014) intradermal route on 11 October 2013. After received FLUZONE ID, immediately afterwards, patients reported itching at site spreading to face and neck, and eyes. Patient's received therapy with BENADRYL or ranitidine. The event was resolved. List of documents held by sender: none.
Received expired booster dose/inadvertantly gave Moderna Covid vaccine after its expiration date; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received expired booster dose/inadvertantly gave Moderna Covid vaccine after its expiration date) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 035C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 25-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received expired booster dose/inadvertantly gave Moderna Covid vaccine after its expiration date). On 25-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Received expired booster dose/inadvertantly gave Moderna Covid vaccine after its expiration date) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications information was reported. Treatment medication was not reported.  It was reported that the vaccine was past the 30 days in the refrigerator and the date the vial was initially stored in the refrigerator was 16sep21. The vial did not undergo any temperature excursions.   Most recent FOLLOW-UP information incorporated above includes: On 28-Oct-2021: Follow-up received on 29-oct-2021, added reporter occupation
Swelling of lymph nodes in chest on same side of body vaccine was delivered (left side)
Intermittent headaches - I usually do not get headaches. Ongoing, since two days post vaccine Lethargy and fatigue - ongoing since one or two days post vaccine
April 15, 2000 pt had increase temp. 103F, chills and sweats. Also had headache and back pain noticed 3-4 inch swelling where yellow fever was given. Resolved itself in 3 days without treatment.
Pt seen for 4 month well check 11/9/18. Doing well. No illness before. Fully well at well check. Normal exam. Received normal 4 month vaccines. Seemed well all afternoon and early /mid evening. Mom noticed later that eve around 9 pm that pt acted hungry but did not want to nurse when offered. When placing down to change diaper, pt vomited solids from earlier that day. Immediately then pt turned pale, white, limp all body, lips started turning blue eyes were always open but appeared lethargic. Mom picked up and gave back slaps. Pt responded and then gradually became more alert. EMS had been called- brought to ER noted to have normal exam, all vital signs stable - monitored over 2 hours. No local vaccine reaction at thighs. Felt likely apnea reaction to choking. Dx Unexplained event. Note pt has mild GE reflux- no past episodes before per mom. No new exposures. No cough, congestion, rashes, diarrhea or other symptoms. Temp at ER -99.  Discharged as seemed well. Temp next day 11/10- low grade 99-100, breastfeeding overall well although not quite himself, no other symptoms, no more vomiting. 11/11 and 11/12- fully well, nursing well, no fever, no vomiting, seemed well. Seen in clinic 11/12/18- alert, comfortable, normal exam. FH of mom with passing out as child with pain, MGM with WBW and A fib-  EKG done for pt in office- normal.
24 hours post-injection started with redness and pain to Left deltoid injection site and has gradually worsened with 1.5inch circular area of induration and redness and warm to touch
Extreme fatigue for 3 days, nausea for 3 days, fever/chills for 2 days, headache/body aches, swollen lymph nodes under arm and at the left clavicle.
Oval reddened area approximately 8 inches around injection site on upper outer arm.  Redness was first noticed 10 days after vaccine. No pain. No itching.
Information has been received from a Doctor of Pharmacy concerning an approximately 50 year old male who was vaccinated with "at least nine" doses of Hep B vaccine. Subsequently the pt experienced elevated liver function tests.  No further information is available.
Itching, pain, swelling. Pt was given injection at pharmacy was seen in PCP office for f/u on Sx. Pt was Rx'd SOLUMEDROL 125mg IM & DECADRON pak. Reaction was from pneumo on (R) side.
about 90 minutes after getting shot I blacked out 3 times over a period of about 40 minutes